Self-reported outcomes during treatment with tumour necrosis factor [agr] inhibitors in patients with rheumatoid arthritis

The objective of this study was to study how patients with rheumatoid arthritis (RA) self-report their experience of disease-related symptoms (fatigue, morning stiffness, pain) and their ability to cope with everyday life (capacity) using a nurse-led structured follow-up during the first year after starting treatment with tumour necrosis factor [agr] (TNF-[agr]) inhibitors. Thirty-nine patients, who were being treated for their RA in our outpatient rheumatology clinic and were beginning treatment with TNF-[agr] inhibitors, agreed to evaluate and self-report their experience of fatigue, morning stiffness, pain, and capacity using the visual analogue scale (VAS) every third month during their first year of treatment. A quantitative method was used to study the changes in these four variables. In addition, at the same time, we studied the relationship between self-reported capacity and each of the three symptoms. After 12 months’ treatment with TNF-[agr] inhibitors all changes were statistically significant. Baseline and 12 months’ capacity correlated significantly with fatigue, morning stiffness and pain In addition, the median change in self-reported capacity correlated significantly with the median change in each of the three symptoms.

During the first year of treatment with TNF-[agr] inhibitors, patients reported decreased fatigue, morning stiffness and pain, while their capacity increased. The increased capacity rate closely followed the decrease in symptom rate.

Sidona-Valentina Bala, Kristina Forslind, Marie Edwinson Månsson. Self-reported outcomes during treatment with tumour necrosis factor [agr] inhibitors in patients with rheumatoid arthritis. Musculoskeletal Care, 6 Nov 2009, online article ahead of print

Neck Pain

Out of all 291 conditions studied in the Global Burden of Disease 2010 Study, neck pain ranked 4th highest in terms of disability and 21st in terms of overall burden.

Speak your mind

Your email will not be published.